4DMedical Ltd (AU:4DX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd has announced a change in the director’s interest, with Dr. Robert Alan Figlin receiving 60,147 Restricted Stock Units as part of his remuneration package. These performance rights have a valuation of $36,250 and are set to vest on January 1, 2025. The issuance was approved at the company’s Annual General Meeting held on November 20, 2024.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.